Non-response to Interleukin-1 Antagonist Canakinumab in Two Patients with Refractory Pyoderma Gangrenosum and Hidradenitis Suppurativa.
Pyoderma gangrenosum and hidradenitis suppurativa are skin conditions characterized by an intense neutrophil-mediated inflammatory response that is often difficult to effectively treat. Successful use of interleukin (IL)-1β inhibition using canakinumab and anakinra has been reported in patients with...
| Publicado en: | Journal of Clinical & Aesthetic Dermatology Vol. 10; no. 9; pp. 36 - 39 |
|---|---|
| Autores principales: | , , , |
| Formato: | Journal Article |
| Publicado: |
Matrix Medical Communications, LLC
Sep2017
|
| Acceso en línea: | Ver este registro en EBSCOhost |